In the simplest sense, we’re a company that creates solutions. More specifically, we design novel access device technology for neurovascular interventions and unmet clinical needs. Because in the precious seconds that surround a stroke emergency, clinicians need technology that delivers. That’s where we come in.
Location: United States, California, Fremont
Employees: 51-200
Total raised: $22M
Founded date: 2016
Investors 1
| Date | Name | Website |
| - | River Citi... | rccf.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.02.2021 | Series C | $22M | - |
Mentions in press and media 4
| Date | Title | Description |
| 19.04.2025 | FDA Classifies Q’Apel Medical Inc.’s Worldwide Medical Device Recall and Discontinuation of its 072 Aspiration System (Hippo) as Class I | Summary Company Announcement Date: April 18, 2025 FDA Publish Date: April 18, 2025 Product Type: Medical Devices Reason for Announcement: Recall Reason Description Distal Tip Design outside scope of 510k clearance Company Name: Q’Apel Medic... |
| 12.02.2021 | Q’Apel Medical Raises $22M in Funding | Q’Apel Medical, Inc., a Fremont, Calif.-based neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, raised $22M in Series C funding. The round included River Cities C... |
| 11.02.2021 | Q'Apel Medical Raises $22M in Series C | FREMONT, CA, Q'Apel Medical announced today it has raised $22M in Series C funding. >> Click here for more funding data on Q'Apel Medical >> To export Q'Apel Medical funding data to PDF and Excel, click here Q'Apel Medica... |
| - | Q'Apel Medical | “Revolutionizing neurovascular access.” |